PCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PCRX Shares Outstanding History and PCRX YTD Return |
PCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PCRX Shares Outstanding History and PCRX YTD Return |
PCRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+20.77% CAGR Mouse over chart for data details
|
PCRX Stock Price Chart |
About Pacira BioSciences Inc |
Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and iovera°®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve. We show 50 historical shares outstanding datapoints in our PCRX shares outstanding history coverage, used to compute PCRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PCRX market cap history over the course of time is important for investors interested in comparing PCRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PCRX versus a peer is one thing; comparing PCRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PCRX can fluctuate over the course of history. With this page we aim to empower investors researching PCRX by allowing them to research the PCRX market cap history. |
PCRX Current Stock Quote |
Free PCRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
PCRX Share Performance |
Market Cap Peers |
Pacira Pharmaceuticals (PCRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
PCSA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.